SHL Medical

16/10/2026

Can you change injection time without changing the patient-side needle?

With Magnitude’s latest Needle Isolation Technology (NIT), the patient-side and cartridge-side needles can be optimized independently.

SHL Medical’s Christina Stevens explains what that can mean for injection performance and clinical flexibility in large-volume delivery.

15/10/2026

Moving a therapy from intravenous (IV) to subcutaneous (SC) involves changes beyond the route of administration.

Different formulation requirements, higher delivery volumes, device usability, and the potential for home administration can all influence the SC development strategy. Advances in formulation and device technology are expanding what’s possible in SC administration while introducing new considerations for device selection and design.

SHL Medical’s Courtney Nicholas Sutton, Head of Portfolio Strategy, will join industry experts at PODD® for a panel to discuss how IV-to-SC delivery is evolving. The panel will explore the factors driving this shift, including patient experience, healthcare efficiency, and the technologies enabling new approaches to SC administration.

Join the discussion on October 30 at 2:00 PM to learn what the evolving IV-to-SC landscape means for drug delivery strategy.

14/10/2026

Volume is only one line in the brief. Viscosity, injection time, needle configuration, and device format can all shape the right platform fit.

SHL Medical’s Thomas James explains what Magnitude offers pharma teams as large-volume combination product program needs evolve.

13/10/2026

Research is redefining the parameters for 2–5 mL subcutaneous delivery.

At PODD®, Alex Lyness, Head of Innovation Strategy and Applied Research at SHL Medical, will take the podium to share the latest research on large-volume delivery, including experimental and imaging methods used to assess its feasibility.

He will discuss how findings across needle geometries, dose volumes, viscosities, and delivery rates can guide system selection and development strategies.

See what the latest evidence could mean for large-volume drug delivery programs on October 30 at 11:50 AM.

12/10/2026

What actually changes when an autoinjector evolves? For Magnitude, it goes beyond a new name.

SHL Medical’s Madison Hill explains how the platform has evolved from Maggie, with changes focused on usability, injection performance, and greater flexibility around the delivery configuration.

11/10/2026

What makes Zug the right place for our next stage of growth?

Journalist Maurizio Minetti recently visited our new headquarters and production site at Tech Cluster Zug to look at the story behind the site.

CEO Ulrich Faessler and Head of Operations Sherline Wunder share what Zug brings to SHL Medical, from proximity to European customers to the role the new site will play in our global manufacturing footprint.

Read the full feature in Luzerner Zeitung (in German): https://bit.ly/4jFNPI1

The feature has since been syndicated across 19 publications and editions in Switzerland.

10/10/2026

This year’s theme for World Mental Health Day, "lived experiences heard: real voices, real change", highlights how listening to people’s experiences can help create more meaningful and inclusive mental health support.

At SHL Medical, we recognize that wellbeing can be shaped by many aspects of life beyond the workplace. Our Employee Assistance Program provides access to professional mental health resources, complemented by local initiatives and sessions that address different aspects of wellbeing, from parenting and caregiving to building greater awareness of stress and strengthening emotional resilience. Together, these forms of support reflect the different experiences and needs our people may have throughout their lives.

On Mental Health Day, we are reminded that support starts with deeply understanding people’s experiences. At SHL Medical, by listening to the different realities our people may face, we aim to create a workplace where employees feel heard and have access to support when they need it.

10/10/2026

Innovation in self-injection was a central theme throughout PDA Universe 2026, with experts from across the industry coming together to share knowledge and experiences.

At SHL Medical, we welcomed conversations with pharmaceutical and device leaders on topics spanning usability, device-container interactions, and large-volume delivery, exchanging perspectives on the challenges and opportunities shaping the field.

Here's a look back at our week in Palm Springs.

09/10/2026

Across three days at CPHI Milan, we exchanged perspectives on evolving therapy needs, specialized drug delivery, emerging markets, and the device strategies behind successful combination product programs.

Relive the highlights from Milan 👇 and see what you may have missed.

08/10/2026

A Partnership Innovation Award is coming home from Palm Springs. 🏆

SHL Medical’s Alex Lyness, PhD and John Burke of Team Consulting received the award at PDA Universe 2026 in Palm Springs for their joint work on imaging large-volume subcutaneous injection deposition in tissue.

The research looks at what happens once large-volume injection enters tissue, and how that evidence can inform device and formulation decisions.

And the timing was fitting: Magnitude, our cartridge-based autoinjector for large-volume delivery, made its PDA Universe debut the same week.

See the full story 👉 https://bit.ly/4i7NZXv

SHL Medical is the world leader in designing, developing, and manufacturing advanced drug delivery devices like autoinjectors and pen injectors. Read more..